Association of chronic kidney disease categories defined with different formulae with major adverse events in patients with peripheral vascular disease

Atherosclerosis

Volumn 232, Issue 2, 2014, Pages 289-2297

  Golledge, Jonathan ^a,b   Ewels, Carla ^a   Muller, Reinhold ^a   Walker, Phillip J ^c,d  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Chronic kidney disease; Estimated glomerular filtration rate; Peripheral vascular disease

Indexed keywords

CREATININE;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; BLOOD; CHRONIC KIDNEY FAILURE; COMORBIDITY; ESTIMATED GLOMERULAR FILTRATION RATE; FOLLOW UP; INCIDENCE; MULTICENTER STUDY; RISK FACTOR; TREATMENT OUTCOME;

CHRONIC KIDNEY DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; PERIPHERAL VASCULAR DISEASE;

AGED; COMORBIDITY; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84892868566     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.034     Document Type: Article

References (38)

1. Eckardt K.U., Coresh J., Devuyst O., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013, 382:158-169.
2. Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013, 382:339-352.
3. Layden J., Michaels J., Bermingham S., Higgins B. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ 2012, 345:e4947. Guideline Development Group.
4. Rooke T.W., Hirsch A.T., Misra S., et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2011, 58:2020-2045.
5. European Stroke Organisation, Tendera M., Aboyans V., Bartelink M.L., et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2851-2906. ESC Committee for Practice Guidelines.
6. Nicolaides A.N., Allegra C., Bergan J., et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 2008, 27:1-59.
7. Wattanakit K., Folsom A.R., Selvin E., Coresh J., Hirsch A.T., Weatherley B.D. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. JAm Soc Nephrol 2007, 18:629-636.
8. Garimella P.S., Hart P.D., O'Hare A., DeLoach S., Herzog C.A., Hirsch A.T. Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis 2012, 60:641-654.
9. Florkowski C.M., Chew-Harris J.S. Methods of estimating GFR-different equations including CKD-EPI. Clin Biochem Rev 2011, 32:75-79.
10. Moynihan R., Glassock R., Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ 2013, 347:f4298.
11. Saratzis A., Sarafidis P., Melas N., Saratzis N., Kitas G. Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair. JVasc Surg 2013, 58:879-885.
12. Lacroix P., Aboyans V., Desormais I., et al. Chronic kidney disease and the short-term risk of mortality and amputation in patients hospitalized for peripheral artery disease. JVasc Surg 2013, 58:966-971. COPART Investigators.
13. Liang K.W., Kuo H.N., Lee W.L., et al. Different mid-term prognostic predictors of major adverse events in diabetic and nondiabetic peripheral artery disease presenting with critical limb ischemia. Angiology 2013 Feb 6, [Epub ahead of print].
14. Romero J.M., Bover J., Fite J., Bellmunt S., Dilmé J.F., Camacho M., et al. The modification of diet in renal disease 4-calculated glomerular filtration rate is a better prognostic factor of cardiovascular events than classical cardiovascular risk factors in patients with peripheral arterial disease. JVasc Surg 2012, 56:1324-1330.
15. Kumakura H., Kanai H., Aizaki M., et al. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. Vasc Med 2011, 16:422-427.
16. Ohrlander T., Dencker M., Dias N.V., Gottsäter A., Acosta S. Cardiovascular predictors for long-term mortality after EVAR for AAA. JVasc Surg 2010, 52:110-117.
17. Jaffery Z., Greenbaum A.B., Siddiqui M.F., et al. Predictors of mortality in patients with lower extremity peripheral arterial disease: 5-year follow-up. JInterv Cardiol 2009, 22:564-570.
18. Pasqualini L., Schillaci G., Pirro M., et al. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. JIntern Med 2007, 262:668-677.
19. Owens C.D., Ho K.J., Kim S., et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. JVasc Surg 2007, 45:944-952.
20. O'Hare A.M., Bertenthal D., Shlipak M.G., Sen S., Chren M.M. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. JAm Soc Nephrol 2005, 16:514-519.
21. Evans M., van Stralen K.J., Schön S., et al. Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transplant 2013, 28:2518-2526. On the behalf of the ERA-EDTA Registry and the Swedish Renal Registry collaboration.
22. Golledge J., Cronin O., Iyer V., Bradshaw B., Moxon J.V., Cunningham M.A. Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis 2013, 229:549-555.
23. Peduzzi P., Concato J., Kemper E., Holford T.R., Feinstein A.R. Asimulation study of the number of events per variable in logistic regression analysis. JClin Epidemiol 1996, 49:1373-1379.
24. Palamuthusingam D., Quigley F., Golledge J. Implications of the finding of no significant carotid stenosis based on data from a regional Australian vascular unit. Ann Vasc Surg 2011, 25:1050-1056.
25. Parr A., Buttner P., Shahzad A., Golledge J. Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. Am J Cardiol 2010, 105:895-899.
26. Golledge J., Jayalath R., Oliver L., Parr A., Schurgers L., Clancy P. Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis 2008, 197:428-434.
27. Parr A., McCann M., Bradshaw B., Shahzad A., Buttner P., Golledge J. Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. JVasc Surg 2011, 53:28-35.
28. Magee R., Quigley F., McCann M., Buttner P., Golledge J. Growth and risk factors for expansion of dilated popliteal arteries. Eur J Vasc Endovasc Surg 2010, 39:606-611.
29. Porter J.M., Moneta G.L. Reporting standards in venous disease: an update. International consensus committee on chronic venous disease. JVasc Surg 1995, 21:635-645.
30. Eknoyan G., Hostetter T., Bakris G.L., et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003, 42:617-622.
31. Van Campenhout A., Moran C.S., Parr A., et al. Role of homocysteine in aortic calcification and osteogenic cell differentiation. Atherosclerosis 2009, 202:557-566.
32. Björk J., Grubb A., Sterner G., Nyman U. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort. Scand J Clin Lab Invest 2011, 71:232-239.
33. Anderson J.L., Adams C.D., Antman E.M., et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable Angina/Non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 123:e426-e579. 2011 Writing Group Members; ACCF/AHA Task Force Members.
34. Wright L., Hill K.M., Bernhardt J., et al. Stroke management: updated recommendations for treatment along the care continuum. Intern Med J 2012, 42:562-569. National Stroke Foundation Stroke Guidelines Expert Working Group.
35. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
36. Matsushita K., Mahmoodi B.K., Woodward M., et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAm Med Assoc 2012, 307:1941-1951. Chronic Kidney Disease Prognosis Consortium.
37. Oh J., Kang S.M., Hong N., et al. The CKD-EPI is more accurate in clinical outcome prediction than MDRD equation in acute heart failure: data from the Korean Heart Failure (KorHF) registry. Int J Cardiol 2013, 167:1084-1087. KorHF Registry.
38. Kidney Health Australia. GFR calculator. Available from. [accessed 30.08.13]. http://www.kidney.org.au/HealthProfessionals/GFRCalculatorCKDEPI/tabid/803/Default.aspx.